Skip to search formSkip to main contentSkip to account menu

blocking factor

Known as: blocks factor 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2016
2016
Purpose Specific immunoglobulin G4 (sIgG4) and immunoglobulin E (IgE)-blocking factors produced by subcutaneous immunotherapy… 
2016
2016
Background: A major problem of venom-specific immunotherapy (VIT) is the absence of reliable parameters for deciding treatment… 
2009
2009
Gynec. Invest. 1974;5:7-64 Scientific Abstracts 1 Systemic and Pulmonary Hemodynamic Resposes to Neurotransmitters during Fetal… 
2005
2005
Recently, we described the presence of a blocking factor (BF) in rat serum, which inhibited the histamine release from rat mast… 
2005
2005
Recently, we described the presence of a blocking factor (BF) in rat serum which inhibited the histamine release from rat mast… 
1991
1991
The activity of the blocking factor (BF) was studied in 88 patients affected by recurrent abortion syndrome (RAS) by means of the… 
Highly Cited
1990
Highly Cited
1990
Serum ultrafiltrates (SUF) from human patients with different types of cancer contain a blocking factor (BF) that inhibits the… 
1983
1983
A blocking factor (BF) was obtained from normal and rat reaginic serum which inhibited the passive cutaneous anaphylactic (PCA… 
1977
1977
The effects of chemotherapy, with nitrosoureas or dimethyl-triazeno-imidazole-carboxamide (DTIC), or immunotherapy with Bacillus… 
1975
1975
Tumor-specific, cell-mediated immune responses (CMI) in mice were measured during the growth of transplantable tumors with the…